AU2001257117A1 - Sitosterolemia susceptibility gene (ssg): compositions and methods of use - Google Patents

Sitosterolemia susceptibility gene (ssg): compositions and methods of use

Info

Publication number
AU2001257117A1
AU2001257117A1 AU2001257117A AU5711701A AU2001257117A1 AU 2001257117 A1 AU2001257117 A1 AU 2001257117A1 AU 2001257117 A AU2001257117 A AU 2001257117A AU 5711701 A AU5711701 A AU 5711701A AU 2001257117 A1 AU2001257117 A1 AU 2001257117A1
Authority
AU
Australia
Prior art keywords
sitosterolemia
ssg
compositions
methods
susceptibility gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001257117A
Inventor
Joshua Schultz
Bei Shan
Hui Tian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tularik Inc
Original Assignee
Tularik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tularik Inc filed Critical Tularik Inc
Publication of AU2001257117A1 publication Critical patent/AU2001257117A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
AU2001257117A 2000-04-18 2001-04-18 Sitosterolemia susceptibility gene (ssg): compositions and methods of use Abandoned AU2001257117A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US19846500P 2000-04-18 2000-04-18
US60/198,465 2000-04-18
US20423400P 2000-05-15 2000-05-15
US60/204,234 2000-05-15
PCT/US2001/012758 WO2001079272A2 (en) 2000-04-18 2001-04-18 Sitosterolemia susceptibility gene (ssg): compositions and methods of use

Publications (1)

Publication Number Publication Date
AU2001257117A1 true AU2001257117A1 (en) 2001-10-30

Family

ID=26893814

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001257117A Abandoned AU2001257117A1 (en) 2000-04-18 2001-04-18 Sitosterolemia susceptibility gene (ssg): compositions and methods of use

Country Status (3)

Country Link
US (4) US7033810B2 (en)
AU (1) AU2001257117A1 (en)
WO (1) WO2001079272A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890896B1 (en) 1999-11-18 2005-05-10 Ceremedix, Inc. Compositions and methods for counteracting effects of reactive oxygen species and free radicals
AU2001257117A1 (en) * 2000-04-18 2001-10-30 Tularik, Inc. Sitosterolemia susceptibility gene (ssg): compositions and methods of use
WO2002027016A2 (en) * 2000-09-25 2002-04-04 The United States Of America, Represented By Secretary, Department Of Health And Human Services Gene involved in dietary sterol absorption and excretion and uses therefor
WO2002081691A2 (en) * 2000-11-20 2002-10-17 Tularik Inc. Abcg5 and abcg8: compositions and methods of use
US8031338B2 (en) * 2004-12-02 2011-10-04 Vanderbilt University Measuring Forster resonance energy transfer with polarized and depolarized light
US11525155B2 (en) * 2013-03-18 2022-12-13 Qiagen Gmbh Stabilisation of biological samples
EP2976426A1 (en) * 2013-03-18 2016-01-27 Qiagen GmbH Stabilization and isolation of extracellular nucleic acids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138493B1 (en) * 1998-11-30 2006-11-21 The United States Of America As Represented By The Department Of Health And Human Services ATP-binding cassette protein responsible for cytotoxin resistance
WO2000058473A2 (en) * 1999-03-31 2000-10-05 Curagen Corporation Nucleic acids including open reading frames encoding polypeptides; 'orfx'
AU2001257117A1 (en) * 2000-04-18 2001-10-30 Tularik, Inc. Sitosterolemia susceptibility gene (ssg): compositions and methods of use

Also Published As

Publication number Publication date
US20050214850A1 (en) 2005-09-29
US7229816B2 (en) 2007-06-12
US7662376B2 (en) 2010-02-16
US20100184096A1 (en) 2010-07-22
US20020081687A1 (en) 2002-06-27
WO2001079272A2 (en) 2001-10-25
US20080009608A1 (en) 2008-01-10
WO2001079272A3 (en) 2002-08-29
US7033810B2 (en) 2006-04-25
US8257934B2 (en) 2012-09-04

Similar Documents

Publication Publication Date Title
AU2001241474A1 (en) Biosensor compositions and methods of use
AU2002332020A1 (en) Compositions for oral gene therapy and methods of using same
AUPR807801A0 (en) Soil probe insertion arrangement and method of use
AU2002258790A1 (en) Novel microarrays and methods of use thereof
AU2003261449A1 (en) Compositions for rna interference and methods of use thereof
AU2002314466A1 (en) Withasol and methods of use
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2002350332A1 (en) Methods of parallel gene cloning and analysis
AU2001245987A1 (en) Compositions and methods for gene therapy
AU2002367903A1 (en) Biologic-chemical herbicide compositions and methods of use
AU2002256543A1 (en) Compositions containing heteropolymers and methods of using same
AU2001257117A1 (en) Sitosterolemia susceptibility gene (ssg): compositions and methods of use
AU2001293048A1 (en) Antiviral compositions and methods of use
AU2002363938A1 (en) Methods and use of motoneuronotropic factors
AU6094200A (en) Nor gene compositions and methods for use thereof
AU2001261496A1 (en) Luxo-sigma54 interactions and methods of use
AU2001243640A1 (en) Compositions and methods for simultaneous detection of multiple biological entities
AU2002352696A1 (en) Cell substrates and methods of use thereof
AU2001264845A1 (en) Nucleotide sequences encoding ramosa 1 gene and methods of use for same
AU2001268053A1 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof
AU2001292468A1 (en) Methods and means of rna analysis
AU2002355432A1 (en) Kavalactone compositions and methods of use
AUPQ760400A0 (en) Herbical formulations and methods of use thereof
AU2002364195A1 (en) Plant msh2 sequences and methods of use
AU2001291195A1 (en) Nucleotide and protein sequence of helios 3 and methods of use